📅 Wednesday, 18 March 2026
⏰ 16:30–19:15
📍 MRC Laboratory of Molecular Biology (LMB) Cambridge CB2 0QH
Programme includes:
🔷 Registration, refreshments and networking☕
🔷 Introduction – Jan Löwe (Director of LMB) and Cathy Tralau-Stewart (Director of Milner Therapeutics Institute)
🔷 Sven Truckenbrodt (LMB) – Molecular Brain Mapping
🔷 Amparo Güemes González (Department of Engineering at the University of Cambridge) – novel therapies based on electrical interfaces with the nervous system and using metabolic bioelectronics to target the brain, vagus nerve, and enteric nervous system
🔷 ‘Neurotech Therapies for Brain and Neurological Conditions: Friend or Foe?’ – a lively panel discussion chaired by Cathy Tralau-Stewart (Director of Milner Therapeutics Institute)
🔷 Informal networking with like-minded thinkers, innovators and entrepreneurs
If you’re curious about how Cambridge NeuroWorks is building a future where neurological conditions no longer limit human potential, register for this free event today ⬇️
Further Info and RegistrationPosted on 11/03/2026